Covered recipient · General Payments record
MELODY H KWONG
Physician Assistants & Advanced Practice Nursing Providers Physician Assistant
General Payments · PY2021–2024
$540.72
- Reported across 22 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $420.25 | 16 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Amgen Inc. | $105.47 | 4 |
| GENZYME CORPORATION | $86.44 | 2 |
| ABBVIE INC. | $72.65 | 3 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $57.02 | 3 |
| Incyte Corporation | $39.33 | 2 |
| Lilly USA, LLC | $30.76 | 1 |
| Almirall LLC | $28.58 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (16)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $26.76 | 01/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107495510 | CMS |
| ABBVIE INC. | $21.91 | 05/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107495512 | CMS |
| ABBVIE INC. | $23.98 | 08/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107495514 | CMS |
| Almirall LLC | $28.58 | 01/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1120636952 | CMS |
| Amgen Inc. | $26.83 | 02/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117604481 | CMS |
| Amgen Inc. | $20.47 | 04/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117604483 | CMS |
| Amgen Inc. | $28.58 | 10/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117604485 | CMS |
| Amgen Inc. | $29.59 | 12/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117604487 | CMS |
| GENZYME CORPORATION | $45.71 | 04/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139809493 | CMS |
| GENZYME CORPORATION | $40.73 | 10/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139809561 | CMS |
| Incyte Corporation | $24.36 | 09/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141252128 | CMS |
| Incyte Corporation | $14.97 | 11/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141268157 | CMS |
| Lilly USA, LLC | $30.76 | 03/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135820060 | CMS |
| Novartis Pharmaceuticals Corporation | $22.49 | 02/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1087104258 | CMS |
| Novartis Pharmaceuticals Corporation | $17.44 | 05/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1087104260 | CMS |
| Novartis Pharmaceuticals Corporation | $17.09 | 11/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1087104262 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2021 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.